CG Oncology (NASDAQ:CGON – Get Free Report) had its price target dropped by research analysts at Royal Bank Of Canada from $81.00 to $79.00 in a report released on Friday,Benzinga reports. Get CG Oncology alerts:Check Out Our Latest Report on CG OncologyCG Oncology Stock PerformanceShares of CGON traded down $0.73 during trading hours on Friday, hitting $74.11. Key Stories Impacting CG OncologyHere are the key news stories impacting CG Oncology this week:Positive Sentiment: Analysts raised price targets. CG Oncology second-quarter resultsCG Oncology reported a loss of $0.90 per share, wider than the $0.66 consensus loss and the $0.54 loss reported a year earlier. Recommended StoriesReceive News & Ratings for CG Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CG Oncology and related companies with MarketBeat.com's FREE daily email newsletter.